LexaGene Holdings Inc. (CVE:LXG – Get Free Report) dropped 19.2% during mid-day trading on Tuesday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares were traded during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Down 19.2 %
The stock has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26. The company has a current ratio of 1.39, a quick ratio of 1.13 and a debt-to-equity ratio of 138.01. The stock’s 50-day moving average price is C$0.11 and its 200-day moving average price is C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
See Also
- Five stocks we like better than LexaGene
- Pros And Cons Of Monthly Dividend Stocks
- Hasbro’s Management Made All the Right Calls This Quarter
- Insider Trading – What You Need to Know
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Stock Sentiment Analysis: How it Works
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
